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Summary 
Naive and memory B  cells were isolated from human tonsils and examined for expression of 
APO-1/Fas and for their sensitivity to the APO-l-dependent apoptosis. APO-1 was found to 
be constitutively expressed on memory but not on naive B cells. The susceptibility of both cell 
types to the APO-1 apoptotic pathway was acquired upon CD40 triggering and was correlated 
with increased expression of the APO-1  receptor. Both naive and memory B  cells were pro- 
tected from the APO-l-mediated death signal after dual ligation of the Ag receptor and CD40. 
Our findings suggest that the APO-1  pathway controls the  specificity of B  cell responses to 
T-dependent Ags and that occupancy of the Ag receptor dictates the outcome of APO-1 liga- 
tion on B cell survival. 
I 
mmunization with a T  cell-dependent Ag induces the B 
.cell clones bearing the appropriate antigenic specificity to 
initiate the formation of germinal centers (GC) 1 where they 
differentiate into either precursors of plasma cells or mem- 
ory B cells (1). There is no dispute that the CD40 molecule 
expressed on B  cells and its T  cell-bound ligand gp39 play 
a critical role in this maturation process. In particular, liga- 
tion of CD40 has been shown to be instrumental in B  cell 
proliferation  (2), Ig isotype switching (3), rescue of high af- 
finity B  cell mutants in  GC  (4),  and generation of B  cell 
memory (5, 6). A distinctive feature of the CD40 signaling 
pathway is that it is Ag nonspecific and  genetically unre- 
stricted (7). This implies that interactions between T  and B 
cells  have to be tightly regulated in  order to prevent the 
stimulation of bystander or self-reactive B cells.  It is gener- 
ally accepted that the rapid turnover and CD40-dependent 
downregulation  of the  CD40  ligand  (CD40-L)  on  acti- 
vated T  cells  (8-10)  prevent the activation of B  cells with 
unwanted  specificity.  However,  several lines  of evidence 
suggest that the APO-1  (Fas/CD95)/APO-1  ligand system 
may be an additional  backup  mechanism of immunosup- 
pression operating to preserve the specificity of T-depen- 
dent Ab responses and to censor autoreactive B  cells in the 
periphery.  First,  lpr/lpr mice,  genetically deficient for the 
iAbbreviations used in  this paper: GC,  germinal center; HEL, hen  egg 
lysozyme; ISNT, in situ nick translation assay; MV, measles  virus. 
expression of APO-1  (11),  suffer from an autoimmune dis- 
ease analogous to systemic lupus erythematosus (12) which 
has been described to be partly attributable to an intrinsic B 
cell defect (13,  14).  This has given rise to the idea that the 
defective expression of APO-1  on B cells is directly associ- 
ated with the emergence ofautoreactive B cells in these an- 
imals. Second,  the ligands for both CD40  and APO-1  are 
inducible  on CD4 §  T  cells  after engagement of the TCR 
(2,  15,  16),  suggesting that helper T  cells are equally capa- 
ble of providing activation and death signals  to B cells after 
cognate interaction. Finally, we have recently reported that 
GC B cells express high levels of the APO-1 molecule and 
acquire  sensitivity  to  the  APO-l-mediated  death  signal 
upon engagement of CD40 (17). 
The present study was undertaken  in  order to  gain in- 
sight into the expression and function of APO-1  at differ- 
ent  steps  of the  Ag-driven B  cell  maturation pathway  in 
humans. Experimental procedures allowing the isolation of 
distinct  developmental stages of the  mature human B  cell 
compartment, based on the differential expression of a set 
of surface markers, are now available. In particular, we and 
others  (18-20)  have reported that human memory B  cells 
can be identified according to their unique  pattern of ex- 
pression of IgD, CD38, and CD44. In this report, we have 
compared naive and memory B cells for their expression of 
APO-1  and have examined the activation requirements of 
both  cell types for the  acquisition  of susceptibility to  the 
APO-l-mediated  death  signal.  Our  results  demonstrate 
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cells but not on naive B  cells; and (b) triggering of CD40 
but not surface immunoglobulin  ligation upregnlates APO-1 
on both B  cell subsets and induces their responsiveness to 
APO-l-dependent  apoptosis. Furthermore, dual ligation of 
slgs and CD40 was found to protect naive and memory B 
cells from APO-l-mediated cell death. In contrast, CD40- 
activated GC B  cells were resistant to the protective effect 
afforded by engagement of the Ag receptor, thus suggesting 
that additional molecular mechanisms may operate to block 
the APO-1 signaling pathway in GC. We propose that the 
protection against APO-l-dependent apoptosis induced by 
concurrent ligation of CD40  and the  Ag receptor  allows 
for the targeting of the APO-l-mediated death signal to B 
cells of unrelated antigenic specificity activated through by- 
stander  interaction with  CD40-L-bearing T  cells  in  the 
course of a normal immune response. 
Materials and Methods 
Abs.  The sources of the Abs used for phenotyping, isolation 
of B cell subsets and functional assays are listed in Table 1. 
Reagents.  Purified recombinant IL-2 and IL-10 were gener- 
ous  gifts from  Drs.  A.  Minty (Sanofi,  Lab~ge,  France)  and J. 
Banchereau  (Schering-Plough,  Dardilly,  France),  respectively. 
IL-2 and IL-10 were used at  10 U/ml and 100 ng/ml, respec- 
tively, throughout the study.  A pool of human sera (a gift from 
Dr. F. Wild, INSERM U  404, chosen for their high measles Ab 
titer,  was used for calibration of the measles-specific ELISA. The 
Hall6 strain of measles virus (MV) was grown on Veto cells, then 
semipurified on sucrose gradients as described elsewhere  (21), and 
partially inactivated by UV irradiation before addition to B  cell 
cultures.  A  1/10  s dilution (equivalent to  0.02  PFU/ml) of the 
MV preparation was used for activation of the MV-specific mem- 
ory B cells. 
Cells.  Purified tonsillar B cells were obtained after two roset- 
ting steps with sheep red blood cells followed by depletion of re- 
sidual T  cells using pan-T cell Abs  (CD2,  CD3)  and magnetic 
beads coated with anti-mouse IgG Abs (Dynabeads, Dynal, Oslo, 
Norway). A preparative  magnetic cell separation  system (MACS; 
Miltenyi Biotec, Bergish Gladbach,  Germany) was used to purify 
IgD- B cells according to the protocol described previously (18). 
GC  (CD38+/CD44 -)  and  memory B  ceils (CD38-/CD44  +) 
were isolated from the IgD- population as previously described 
(18). For purification ofGC B cells, IgD- B cells were submitted 
to two successive rounds of depletion, each one involving label- 
ing with an anti-CD44 mAb (clones NKI-P2 andJ 173) and in- 
cubation with magnetic beads  coated with anti-mouse IgG. A 
similar procedure was applied for the isolation of memory B cells; 
this time, labeling of the cells was performed with two different 
anti-CD38 mAbs (clones  IB4  and HB-7).  Cross-contamination 
of GC and memory B cells was routinely <2% as estimated  by 
the  expression  of CD38  and CD44  revealed  by stainings  per- 
formed with FITC or PE-conjugated anti-CD38 and CD44 mAbs. 
Naive (IgD +) B cells were purified from the unfractionated B 
cell population by a negative selection procedure based on the se- 
lective depletion of GC and memory B cells using the anti-CD38 
mAb  IB4  (GC  B  cells) in  combination with  the  anti-CD80 
(B7-1) mAb 104 (GC and memory B cells) and magnetic beads 
coated with anti-mouse IgG. In some experiments, IgD  + B cells 
were negatively selected by sorting after labeling of the GC and 
memory B cells with a combination ofPE-conjugated anti-CD80 
and anti-CD38 mAbs. The mouse Ltk- cell line HR4C6, stably 
expressing  the human Fc~/tklI (CD32),  was kindly provided by 
Dr.  C.  Sautrs  (INSERM U  255,  lnstitut Curie, Paris,  France). 
The CD32 transfectants were treated with 75 ~g/ml rnitomycin 
C (Sigma Chemical Co., St. Louis, MO) 1 h at 37~  before their 
addition to B cell cultures. 
Cultures.  All cultures  were  performed in RPMI  1640  me- 
dium enriched with 10% heat-inactivated FCS, 2 mM L-glutamine, 
100 U/ml penicillin, 100 mg/ml streptomycin, and 2% Hepes (all 
from GIBCO BRL, Gaithersburg,  MD). For functional assays, B 
cells were seeded at 10  s cells per well in round-bottomed 96-well 
microtiter trays at  a final  culture volume of 0.1  (evaluation  of 
DNA synthesis) or 0.25 ml (quantitation of secreted  Igs), except 
for the MV-specific  culture system, in which B cells were seeded 
at 5 ￿  l0  s cells per well in 0.25 ml. For the CD40-mediated acti- 
vation of B  cells, the  cultures were  performed  with  the  anti- 
CD40 mAb G28-5 (22) (100 ng/ml) in the presence of 1 X  104 
mitomycin C-treated  HR4C6  cells. The  anti-CD95/Fas mAb 
APO-1 (23) and its unrelated IgG3-K control were used at a final 
concentration of 200 ng/ml, which was determined, in pilot ex- 
periments, to be optimal for the induction ofapoptosis. For two- 
step cultures,  B cells were first stimulated for 48 h at a density of 
107 cells per well in 6-well plates with either the anti-CD40 mAb 
G28-5 or a combination of anti-K and anti-h IgG1  mAbs (both 
used at a final concentration of 2 Ixg/ml) in the presence ofmito- 
mycin C-treated HR4C6 cells. B cell blasts recovered at the end 
of the  primary culture were washed  and recultured in 96-well 
plates, at a density of 10  s cells per well with the indicated stimuli. 
DNA synthesis was determined by pulsing the cells with [3H]thy- 
midine ([3H]TdR)  for  the  last  16  h  of the  culture period,  lg 
secretion (IgG,  IgM, and IgA) was determined in 12-d culture 
supernatants  by  standard  ELISA  techniques,  as  described  else- 
where (24). 
In some experiments, the results of the prohferation  assays were 
expressed  as  percent response  in control cultures,  calculated  as 
follows: % of the response in control cultures =  [(cpm in stimu- 
lated cultures supplemented with the anti-APO-1 mAb) -  (cpm in 
unstimulated cultures)/(cpm in stimulated cultures supplemented 
with the IgG3-K control) -  (cpm in unstimulated cultures)] ￿  100. 
Detection ofAnti-MV IgG Abs.  For detection of anti-MV IgG 
Ab, flat-bottomed microtiter plates (Immunoplate Maxisorp  F96; 
Nunc, Roskilde, Denmark) were first coated with 0.1  ml of a 
1/800 dilution from a lysate ofMV-infected Vero cells prepared 
in carbonate buffer, pH 9.6, and allowed to incubate overnight at 
4~  Plates were then washed  three times  with PBS containing 
0.05% Tween 20 (Sigma Chemical Co.). Samples were appropri- 
ately diluted, added to the wells in a final volume of 0.1 ml, and 
incubated at room temperature for 90 rain. The plates were then 
washed  as before and 0.2  ml of a  1/2,  500  dilution of a rabbit 
anti-human IgG Ab conjugated to  alkaline  phosphatase  (Dako, 
Glostrup,  Denmark) was added  to each well. After a 90-rain in- 
cubation, plates were washed  and developed with a solution of 
p-nitrophenylphosphate (Sigma Chemical Co.) prepared in dieth- 
anolamine buffer.  The subsequent development of color at 490 
nm was detected on a multichannel spectrophotometer. The val- 
ues were related to a standard serum containing high amounts of 
anti-MV IgG  Ab.  One  ELISA  unit  (EU)  was  defined  as  the 
amount of anti-MV IgG Ab present in a  1/160,000 dilution of 
the standard serum. 
Assay for Programmed Cell Death  (In  Situ  Nick  Translation As- 
say).  For measurement of apoptosis, B cells were seeded in 12- 
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medium. At the times specified in the text, the cultures were har- 
vested and apoptotic cells were quantified using the in situ nick 
translation assay (ISNT), allowing the detection of cells carrying 
DNA single strand breaks, as described elsewhere (25).  Briefly, 
the cells were fixed successively with 1% formaldehyde and 70% 
ethanol. The fixed cells were washed with nick buffer (50  mM 
Tris-HCI, pH 7.8, 5 mM MgC12, 0.1 M  [3-mercaptoethanol, and 
10  ~g/ml BSA) and incubated with a mix,re of 1.3  ~1 dATP, 
dGTP, dCTP, each 0.2 mM (Boehringer Mannheim, Mannheim, 
Germany), 1.6 ~1 nick buffer, 0.3 ~1 1 mM biotinylated-11-dUTP 
(Boehringer Mannheim), and 1 U Escherichia coli  polymerase I (New 
England Biolabs, Beverly, MA) for 90 man at 15~  to complete 
broken DNA strands.  The  cells were  stained with avidin-FITC 
(Immunotech,  Marseille, France) and DNA was  counterstained 
with 10 Ixg/ml propidium iodide before analysis on a FACScan  | 
cytofluorimeter (Becton Dickinson & Co., Mountain View, CA). 
Percent  DNA  fragmentation corresponds to  the  percent green 
fluorescence in the propidium iodide-positive population. 
Immunofluorescence Stainings.  Surface expression of APO-1 was 
measured after labeling performed with the IgG3 APO-1  mAb 
revealed by PE-conjugated goat anti-mouse IgG3 Abs. The stain- 
ing control was performed with a nonbinding IgG3 mAb. Immu- 
nofluorescence  stainings  were  analyzed  on  a  FACScan  |  flow 
cytometer using Lysis software (Becton Dickinson & Co.). To es- 
timate the modulation of the mean fluorescence intensity (MFI) 
of the APO-1 fluorescence peak in cultures of activated B  cells, 
the cytofluorimeter settings were adjusted so that the fluorescence 
histograms of the negative controls, for the different time points 
considered, overlapped completely. 
Results 
CD40  Cross-linking  Upregulates APO-1  Expression  on  B 
Cells, Irrespective of their Maturational  Stage.  We  first  com- 
pared the surface expression of APO-1  on different B  cell 
subsets, before and after stimulation by either immobilized 
Table 1.  Clone  Numbers and Sources of the Abs Used  for Phenotypical and Functional Studies 
Abs  Clone  Source 
CD2  OKT11 
CD3  OKT3 
CD3-FITC  UCHT1 
CD10  44C10 
CD 10-PE  SS2/36 
CD19-PE  HD37 
CD20-FITC  B-Ly-1 
CD38  IB4 
CD38  HB-7 
CD38-PE  HB-7 
CD40  G28-5 
CD44  J173 
CD44-FITC  J173 
CD44  NKI-P2 
CD80  104 
CD80-PE  L307.4 
CD95/Fas  APO-1 
IgD biotin  Goat Abs 
IgD-PE  Goat Abs 
Igs (H +  L)  Rabbit Abs 
coupled to beads 
K light chain  6El 
k light chain  C4 
Isotype controls 
Mouse IgG1 
Mouse IgG3-K 
Conjugates 
Goat anti-mouse 
Igs-FITC 
Streptavidin-FITC 
American Type Culture Collection, Rockville, MD 
American Type Culture Collection 
Dako 
Dr. M. Letarte, The Hospital for Sick Children, Toronto, Canada 
Dako 
Dako 
Dako 
Dr. F. Malavasi, Laboratorio di Biologia Cellulare, Torino, Italy 
Becton Dickinson 
Becton Dickinson 
Dr. E.A. Clark, University of Washington, Seattle, WA 
Immunotech 
Immunotech 
Dr. C. Figdor, The Netherland Cancer Institute, Amsterdam, The Netherlands 
Immunotech 
Becton Dickinson 
Dr. P. Krammer, German Cancer Research Center 
Sigma Chemical Co. 
Southern Biotechnology Associates, Birmingham, AL 
Bio-Rad Laboratories, kichmond, CA 
lmmunotech 
Immunotech 
Sigma Chemical Co. 
Sigma Chemical Co. 
Dako 
Immunotech 
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CD32 transfectants.  Naive B  cells were negatively selected 
from the purified tonsillar B  cell population by sorting, af- 
ter gating out cells  labeled  with  the  anti-CD80  and  anti- 
CD38 Abs.  GC and memory B  cells were recovered from 
the  IgD-  population  after  immunomagnetic  depletion  of 
CD44 and CD38-bearing cells,  respectively. The results of 
a representative  experiment,  shown in Fig.  1, indicate that 
both GC and memory B cells,  but not naive B cells,  consti- 
tutively express APO-1. However, in contrast with the ho- 
mogeneous  staining  profile  obtained  with  GC  B  cells, 
APO-1  is  expressed  with  variable  levels  of intensity  on 
memory B cells.  Triggering of CD40 induced most naive B 
cells to express APO-1 and strongly enhanced the levels of 
expression  of this  molecule  on  both  GC  (sevenfold  in- 
crease) and memory B  cells  (fourfold increase). Among the 
three B  cell subsets  examined,  GC B.cells were reproduc- 
ibly found  to  express  the  highest  density  of APO-1  after 
CD40  stimulation.  Conversely,  engagement  of the  B  cell 
receptor by immobilized polyclonal anti-Ig Abs did not in- 
duce  APO-1  on  naive  B  cells  and  reduced  the  levels  of 
naive 
B cel~ 
A 
D  -. ~-.-- 
137 
GC 
B cells 
A 
D 
memory 
B cells 
A 
C  .~k. 
Fluorescence intensity 
1190 
Figure 1.  Constitutive and ac- 
67  tivation-induced expression  of 
APO-1  on  naive,  GC,  and 
memory B cells. 2 X 106 B cells 
37  from each subset were stimulated 
for  48  h  with:  the  anti-CD40 
163  mAb  G28-5  (A), an  unrelated 
IgG1  control  mAb  (B)  in  the 
presence of 2 ￿  105 mitomycin 
C-treated HR.4C6 cells, imrno- 
bihzed  polyclonal  anti-lg  Abs 
(C), Viable cells were gated ac- 
cording to  forward versus side 
scatter profiles for the flow cy- 
876  tometry analysis. The bindings of 
the APO-1 mAb and of an iso- 
202  type-matched  control mAb, on 
freshly isolated cells, are  illus- 
76  trated  by the fluorescence profiles 
shown in D and E, respectively. 
(Horizontal axes) log fluorescence; 
137  (vertical  axes) relative cell num- 
bers. MFI values of the fluores- 
cence peaks ofAPO-1  + cells are 
indicated  next  to  the  staining 
profiles. 
APO-1 expression on both GC and memory B  cells.  Simi- 
lar results were obtained when a combination ofanti-K and 
anti-k mAbs presented by the CD32 transfectants was sub- 
stituted to the immobilized polyclonal anti-Ig Abs (data not 
shown). 
APO-1  Ligation Blocks the CD40-dependent Proliferation of 
Naive and Memory B Cells.  We  have  previously  reported 
that APO-1 hgation inhibits  the DNA synthesis promoted 
by anti-CD40 Abs in purified  GC B  cells  (17).  Thus,  we 
next  examined  the  influence  of the  agonistic  anti-APO-1 
mAb on the growth-response of naive and memory B  cells 
promoted  either  by  engagement  of CD40  (G28-5  mAb 
plus  CD32  transfectants)  or triggering  of the  Ag receptor 
(immobilized polyclonal anti-Ig Abs). For this purpose, the 
prohferative responses of B  cells in both activation systems 
was estimated in cultures supplemented  or not with either 
the  anti-APO-1  mAb  or  the  unrelated  IgG3-K  control. 
The results of a representative  experiment depicted in Fig. 
2 show that the CD40-mediated proliferation of naive and 
memory B  cells  was  profoundly  inhibited  by addition  of 
the  anti-APO-1  mAb,  whereas  it  was  unaffected  by  the 
isotype-matched  control  Ab.  In  the  majority  of experi- 
ments,  the maximal levels of inhibition  of the proliferative 
response of CD40-stimulated B  cells brought about by the 
anti-APO-1  mAb were observed between  48 and 72 h  of 
culture. Although the anti-APO-1  mAb induced some in- 
hibition  of the  DNA  synthesis  promoted by immobilized 
anti-Ig Abs, the degree of suppression  evoked by the anti- 
APO-1  mAb was  consistently higher in  CD40-stimulated 
cultures. 
APO-1 Ligation Inhibits CD40- but Not Ag-driven  Ig Syn- 
thesis.  We next addressed the question of the ability of the 
anti-APO-1  mAb to suppress  Ig synthesis.  The  choice of 
the  combination of IL-2 and  IL-10 for these  experiments 
was  motivated  by the  fact  that  these  cytokines efficiently 
support the differentiation of B  cells into Ig-secreting cells, 
both in CD40-dependent culture systems (polyclonal stim- 
ulation;  26)  and  in  CD40-independent  models  in  which 
memory B  cells  are selectively induced for specific Ab pro- 
duction by the Ag.  Thus,  polyclonal Ig synthesis was first 
measured in cultures of naive and memory B cells costimu- 
lated with anti-CD40 Abs, IL-2 and IL-10, in the presence 
or absence of either the anti-APO-1  mAb or the isotype- 
matched unrelated control Ab. As shown in Table 2, APO-1 
ligation on CD40-activated naive and memory B  cells dra- 
matically  impaired  their  ability  to  differentiate  into  Ig- 
secreting cells in response to IL-2 and IL-10, thus exclud- 
ing  the  possibility  that  APO-1  triggering  may  favor  the 
maturation  of B  cells  into  terminally differentiated  plasma 
cells. 
We have recently reported that a typical recall Ag such as 
MV  can  be  used  to  generate  secondary  Ab  responses  in 
vitro  (26a).  This  approach  has  permitted  us  to  conclude 
that the differentiation of memory B cells along the plasma- 
cytoid pathway does not rely upon engagement  of CD40 
and can be achieved by costimulation with the Ag and the 
combination of IL-2 and  IL-10. This  experimental  system 
was thus used to examine the influence of APO-1  trigger- 
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Figure  2.  APO-1  ligation inhibits the prohferative response of anti-CD40-activated naive and memory B  cells.  Isolated naive and memory B  cells 
(10S/well)  were stimulated with the anti-CD40 mAb G28-5 together with mitomycin C-treated HR4C6  (3  ￿  104/well)  cells,  or with immobilized 
polyclonal anti-Ig Abs, in the presence or absence of either the anti-APO-1  mAb or the IgG3-K control mAb (both used at 200 ng/ml). Cells were 
pulsed with [3H]thymidine at the indicated times; cultures were terminated 16 h later. Results correspond to the mean +  SD values of triplicate determi- 
nations. The figure is representative of three separate experiments. The [3H]thymidine incorporation levels in unstimulated control cultures are also indi- 
cated. 
ing on the MV-driven secondary Ab response. The results 
of a representative experiment depicted in Fig.  3 indicate 
that addition of the anti-APO-1  mAb does not affect the 
development of the  in  vitro  secondary  anti-MV  Ab  re- 
sponse. This observation suggests  that the APO-1 signaling 
pathway has no impact on the Ag-driven differentiation of 
memory B  cells into plasma cells,  and further supports the 
hypothesis that CD40 ligation is instrumental in inducing 
the susceptibility of B cells to APO-l-mediated apoptosis. 
APO-1  Ligation on  CD40-activated  Naive  and Memory  B 
Cells Induces Their Apoptosis.  We next determined whether 
the  inhibitory effect of the  anti-APO-1  mAb  on B  cell 
growth  and  differentiation was  mediated through the  in- 
duction of apoptosis.  For this purpose,  the proportion of 
apoptotic cells was estimated by ISNT in cultures of naive 
and memory B cells activated by anti-Ig or anti-CD40 Abs, 
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supplemented or not with either the agonistic anti-APO-1 
mAb or the unrelated IgG3-K control mAb. As shown in 
Table 3,  APO-1  ligation on either unstimulated or anti- 
Ig-activated B cells did not affect the levels of apoptosis oc- 
curring in these cultures. Experiments performed at earlier 
time points (6, 12, and 24 h) demonstrated that addition of 
the anti-APO-1  mAb did not modify the kinetics of entry 
of the  cells  into  apoptosis  in  these  cultures  (data  not 
shown), thus indicating that unstimulated and anti-Ig-acti- 
vated B  cells are resistant to anti-APO-l-induced apopto- 
sis. On  the  contrary, engagement of APO-1  promoted a 
significant rise in the proportion of apoptotic cells in anti- 
CD40-stimulated  cultures for both naive and memory B 
cells.  Taken  together,  these  results  suggest  that:  (a)  the 
APO-1  molecule,  although  constitutively  expressed  on 
memory B  cells, is not readily connected to the cell death Table  2,  APO-1/Fas Ligation Inhibits the Ig Synthesis Elicited by IL-2 and IL-lO  from Anti-CD40--activated  Naive and Memory B Cells 
Ig synthesis 
Naive B cells  Memory B cells 
-Anti-APO-I  +Anti-APO-1  +Ctrl mAb  -Anti-APO-1  +Anti-APO-1  +Ctrl mAb 
la,g  /ml 
Unstimulated  0.5  0.3  0.5  <0.1  <0.1  <0.1 
Anti-CD40  1.4  0.4  0.8  <0.1  <0.1  <0.1 
IL-2+IL-10  5.8  3.1  4.7  1.1  0.9  1.2 
Anti-CD40 + IL-2 + IL-  10  476.0  181.0  483.0  94.1  17.0  101.0 
Isolated naive and memory B cells were either stimulated with or without: (a) the anti-CD40 mAb G28-5 "presented" by the CD32 transfectants; 
(b) IL-2+IL-10; (c) the combination of both stimuli, in the presence or absence of either the anti-APO-1 mAb or the IgG3-K control mAb. The cu- 
mulative IgM, IgG, and IgA levels (expressed in Ixg/ml) were evaluated in 12=d culture supernatants. Data are shown as means of quadruplicate de- 
terminations.  Standard deviations did not exceed  10% of the mean values. The table is representative of three separate experiments. 
ctrl, control. 
pathway;  and  (b)  both  naive and memory B  cells become 
sensitive to anti-APO-l-induced  apoptosis upon activation 
of the CD40 signaling pathway. 
Dual Ligation of CD40 and slgs Protects Naive and Memory 
B  Cells from APO- 1-mediated Cell Death.  As  outlined  in 
the introduction, it is conceivable that B  cells could poten- 
tially be  signaled both  through  CD40  and APO-1,  in the 
context  of a  cognate  interaction with  T  cells.  If this pro- 
posal is correct, it implies the existence of a mechanism that 
would protect Ag-specific B  cell clones from being deleted 
through activation of the APO-l-signaling pathway, in the 
course of an immune response. As the occupancy of the Ag 
receptor itself allows discrimination between the appropri- 
ate B  cell clones and those  bearing an unrelated antigenic 
specificity,  we  speculated  that  the  sIg  signaling pathway 
might influence the outcome ofAPO-1  ligation on B  cell 
survival. To test this hypothesis,  we first examined the in- 
fluence of the agonistic anti-APO-1 mAb on the prolifera- 
tion and differentiation of unfractionated B  cells activated 
by:  (a)  engagement  of  the  Ag  receptor;  (b)  ligation  of 
CD40;  and  (c)  coligation  of the  Ag  receptor  and  CD40. 
The  results  of a  representative  experiment,  illustrated  in 
Fig.  4,  demonstrate  that  the  inhibitory effect  of the  anti- 
APO-l-mAb  on  the  proliferation  and  Ig  response  of 
CD40-activated B  cells is reversed when slgs and CD40 are 
simultaneously cross-linked.  To  confirm that  activation of 
the sIg signaling pathway confers protection against the cell 
death signal mediated by APO-1, we  next compared anti- 
CD40--activated B  ceils with B  cells activated by coligation 
of CD40  and sIgs for their sensitivity to the APO-1  apop- 
4000 
3000 
2000 
1000' 
￿9  -anti-APO-1 
￿9  +anti-APO-1 
[] +ctrl mAb 
MV  IL-2+IL-10  MV 
+IL-2+IL-10 
Figure  3.  APO-1  ligation  on Ag-activated memory B 
cells does not affect the induction of a secondary Ab re- 
sponse. Isolated memory B cells (4 ￿  10  s cells/well in 96- 
well round-bottomed microtiter trays) were stimulated for 
12 d with:  (a) measles virus (MV); (b) the combination of 
IL-2  (10  U/ml)  and  IL-10  (100 ng/ml); and  (c)  MV+ 
IL-2+IL-10. Cultures were  further  supplemented  or not 
with either  the anti-APO-1 mAb or the IgG3-K control 
mAb (used at 200 ng/ml). The levels of specific anti-MV 
IgG Ab production were evaluated in 12-d culture super- 
natants by ELISA. The results correspond to the mean + 
SD values of triplicate determinations and are expressed in 
ELISA units per nil (EU/ml). 
1382  APO-1--dependent Apoptosis of Human B Cell Subsets Table 3.  Sensitivity  of Naive and Memory B Cells to the APO- 1/Fas Apoptotic Pathway Is Acquired upon CD40 Ligation 
Percent apoptotic cells 
Naive B cells  Memory B cells 
Stimuli  -Anti-APO-1  +Anti-APO-1  +Ctrl mAb  -Anti-APO-1  +Anti-APO-1  +Ctrl mAb 
% 
None  77  77  77  80  80  80 
Anti-Ig  64  67  69  69  70  70 
Anti-CD40  35  59  34  47  69  48 
Isolated naive and memory B cells were cultured either with or without: (a) the anti-APO-1  mAb; (b) the IgG3-K control, in the presence or ab- 
sence of either the anti-CD40 mAb G28-5 presented by the CD32 transfectants or immobilized polyclonal anti-Ig Abs. The proportion of apoptotic 
cells was estimated by ISNT after a 48-h culture. Results are expressed as percent apoptotic cells and are representative of  three separate experiments. 
totic  pathway.  For  this  purpose,  the  proportion  of apop- 
totic cells was estimated in cultures of unfractionated  ton- 
sillar B  cells stimulated for 48 h  either with anti-CD40 Abs 
or with  the  combination  of anti-CD40  and  immobilized 
anti-Ig Abs and supplemented or not with the anti-APO-1 
mAb  or  the  IgG3-K  control  mAb.  As  shown  in  Fig.  5, 
CD40-activated  B  cells  were  induced  for  apoptosis  after 
engagement of APO-1, whereas  the simultaneous  trigger- 
ing of CD40 and slgs protected B  cells from the APO-1- 
mediated programmed cell death.  To dissect the sequence 
of events leading to the acquisition  of an APO-l-resistant 
phenotype,  the  sensitivity  of B  cells  to  APO-l-mediated 
apoptosis  was  estimated  in  a  two-step  culture  system  in 
which the Ag receptor was engaged either before  or after 
ligation of CD40.  For this purpose,  both anti-Ig and anti- 
CD40 B  cell blasts  were  generated  by stimulating  B  cells 
for 48 h,  in the presence  of the  CD32 transfectants,  either 
with a combination of anti-K and anti-k mAbs, or with the 
anti-CD40  mAb.  We  deliberately  avoided  the  use  of 
Sepharose-bound  polyclonal anti-Ig Abs for these  experi- 
ments because cells cannot be washed free of this particular 
anti-Ig reagent.  At the  end of the primary culture,  anti-Ig 
and anti-CD40 B  cell blasts were washed, seeded on mito- 
mycin C-treated  CD32  transfectants,  and recultured  with 
anti-CD40  and anti-K/k  mAbs, respectively.  The second- 
ary cultures were further supplemented  or not with either 
the  anti-APO-1  mAb  or  the  unrelated  IgG3-K  control 
mAb. The susceptibility of the two types of blasts to APO- 
1-dependent apoptosis was estimated in a prohferation as- 
say. The same B  cell preparation was tested  in parallel for 
its  sensitivity  to  APO-l-dependent  apoptosis  when  anti- 
CD40  and  anti-K/k  Abs were simultaneously  provided at 
the onset of the culture.  The results of a representative  ex- 
periment, shown in Fig. 6, indicate that neither anti-Ig nor 
anti-CD40  B  cell  blasts  are  efficiently  protected  from 
APO-l-mediated apoptosis,  whereas  the simultaneous  ad- 
dition ofanti-CD40 and anti-K/k mAbs at the initiation of 
the culture completely abrogates the growth-inhibitory ef- 
fect of the anti-APO-1 mAb. 
To  determine  whether  the  protective  signal evoked by 
concurrent engagement of the B  cell receptor and CD40 is 
operative  at all  B  cell maturational  stages,  naive,  GC,  and 
memory  B  cells  were  tested  for  their  sensitivity  to  the 
APO-1  apoptotic pathway after cross-linking of CD40  or ￿9 
dual  ligation  of CD40  and  slgs.  B  cell  proliferation  was 
chosen  as  the  readout  system  for  these  experiments.  As 
shown in Fig.  7, both naive and memory B  cells  acquired 
resistance  against  APO-l-mediated  cell  death  when  they 
were costimulated by anti-Ig and anti-CD40 Abs, whereas 
GC B  cells remained sensitive to the anti-APO-1  mAb in 
the latter culture condition. Taken together, these findings 
suggest  that:  (a)  the  protection  of B  cells  from APO-1- 
mediated  apoptosis  requires  concurrent  ligation  of CD40 
and slgs; and (b) the protective signal generated by engage- 
ment of the Ag receptor is defective in GC B cells. 
Discussion 
The present study highlights three important features of 
the APO-1 apoptotic pathway in mature human B cells: (a) 
APO-1  is not constitutively connected to the intracellular 
death-inducing  pathway;  (b)  the  transduction  of a  death 
signal  through  APO-1  requires  prior  activation  through 
CD40; and (c) the dual engagement of the Ag receptor and 
CD40  protects  naive  and  memory B  cells  from APO-1- 
induced apoptosis. 
The observation that APO-1  is absent  on naive B  cells, 
whereas  it is  expressed  on both  GC and memory B  cells, 
strongly suggests  that  APO-1  expression  in  the  mature  B 
cell  compartment  is  acquired  as  the  consequence  of anti- 
genic stimulation in vivo. However, the finding that cross- 
linking of CD40 can induce expression of APO-1 on naive 
B  cells and their subsequent apoptosis after APO-1 ligation 
indicates that APO-1 can exert its regulatory function both 
at early and late  stages of the Ag-driven B  cell maturation 
process. 
The notion that activation of human B  cells  is a prereq- 
uisite  for the  induction of an APO-1--sensitive phenotype 
has been suggested in a previous report (27). Here, we pro- 
vide evidence that triggering of CD40 but not cross-link- 
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Figure 4.  Engagement of the Ag receptor counter- 
acts the inhibitory effect of the anti-APO-1  mAb on 
the proliferation and differentiation of CD40-activated 
B cells. Unfractionated tonsillar B cells were activated 
by: (a) polyclonal anti-Ig Abs; (b) the anti-CD40 mAb; 
or (c) the combination of anti-CD40 and anti-lg Abs, 
in the presence or absence of either the anti-APO-1 
mAb  or IgG3-K control  mAb  (used at  200  ng/ml). 
DNA synthesis (A) was assessed at day 2, after a 16-h 
pulse with [3H]thymidine. Cultures made for evalua- 
tion  of Ig secretion  (B)  were  further  supplemented 
with the combination of IL-2 and IL-10. All cultures 
were  performed  in  the  presence of mitomycin  C- 
treated HR4C6  cells. The cumulated IgM, lgG, and 
IgA levels were measured in 10-d culture supernatants 
and are expressed in p~g/ml. The results shown corre- 
spond to the mean +  SD values of triplicate (prolifera- 
ton)  and quadruplicate (Ig synthesis)  determinations and 
are representative of three such experiments. 
ing of the Ag receptor confers on B  cells the susceptibility 
to APO-l-mediated apoptosis. First, the anti-APO-1 mAb 
suppressed  the  growth  and  differentiation of anti-CD40- 
activated B  cells  through  the  induction  of apoptosis  but 
only marginally affected the responses of B  cells stimulated 
by anti-Ig Abs.  Second,  APO-1  ligation did not interfere 
with the CD40-independent induction of a secondary anti- 
MV Ab response in vitro. Thus activation of the CD40 sig- 
naling pathway appears to be essential for the development 
of both  APO-l-induced  apoptosis  and  T-dependent  Ab 
responses. This finding implies that the fate of B  cells after 
physical contact with T  helper cells could equally be differ- 
entiation or death.  It can thus be speculated that APO-1- 
mediated apoptosis has to be tightly regulated in vivo in or- 
der to avoid deletion of the responder B  cell clones in the 
course of an ongoing immune  response.  Our current data 
indicate  that  occupancy  of the  Ag receptor itself dictates 
the outcome ofAPO-1  ligation on the survival of activated 
human  B  cells. This  conclusion is coherent with  a  recent 
study (28)  in which  murine  B  cells activated through  the 
Ag  receptor  were  found  to  be  resistant  to  APO-1/Fas- 
dependent  Thl-mediated  apoptosis.  Our  hypothetical 
model (depicted in Fig. 8) predicts that the APO-1  signal- 
ing pathway  on  B  cells is  silenced when  triggered in  the 
context  of an  Ag-specific,  cognate  T-B  cell  interaction, 
due to the engagement of the Ag receptor by the Ag. On 
the contrary, the APO-1 signaling pathway should be fully 
operational if B  cells bearing an irrelevant antigenic speci- 
ficity are stimulated through  CD40  upon interaction with 
activated T  cells. 
Several lines of evidence indicate that APO-1  may also 
play a critical role in the censoring ofautoreactive B  cells in 
the periphery.  In particular, Rathmell et al.  (29)  have  re- 
cently demonstrated that, in double transgenic mice coex- 
pressing the hen-egg lysozyme (HEL) and a B  cell receptor 
specific for HEL, self-reactive B  cells are eliminated through 
an  APO-1/Fas-mediated  mechanism  upon  interaction 
with HEL-specific CD4 + T  cells. At face value, our obser- 
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Figure 5.  Engagement of the Ag receptor protects anti- 
CD40-activated B cells from APO-l-mediated apoptosis. 
Unfractionated tonsillar  B  cells  were  stimulated  by  the 
anti-CD40 mAb in the presence or absence of immobi- 
lized potyclonat anti-Ig Abs. Cultures were further supple- 
mented or not with either the anti-APO-1  mAb or the 
IgG3-~: control mAb (used at 200 ng/ml). All culture con- 
ditions were performed in the presence of mitomycin C- 
treated HR.4C6  cells. The proportions of apoptotic  cells 
were evaluated after a 72-h culture by ISNT. The results 
are expressed as percent apoptotic cells and are representa- 
tive of three such experiments. The proportion of apop- 
totic cells in unstimulated culture is 63%.  Figure  is repre- 
sentative of three such experiments. 
vation that concurrent engagement  of the Ag receptor and 
CD40  protects  B  cells  from  APO-l-mediated  cell  death 
seems difficult to reconcile with the fact that the binding of 
the selfAg does not prevent the APO-l-induced  apoptosis 
of  autoreactive  B  cells,  in  the  experimental  model  de- 
scribed above. However,  there is reason to believe that the 
protection mechanism  afforded by slgs does not operate in 
peripheral self-reactive B  cells.  Indeed, it has been reported 
that B  cells that express a  transgenic HEL-specific  receptor 
and that have been exposed  to moderate  concentrations of 
a  soluble form of HEL,  are  tolerant to  Ag stimulation but 
are still fully responsive to T  cell-derived signals, including 
those  delivered  through  CD40  (30--32).  The  molecular 
mechanism  underlying their anergy has been shown  to be 
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Figure  6.  Protection  of  B  cells  from 
APO-l-dependent apoptosis  is afforded  by 
concurrent ligation of slgs and CD40. Two 
culture  systems  were  applied.  In  the  first, 
the stimulating agents  were simultaneously 
provided at the onset of the culture. In the 
second, B cells were precultured with either 
anti-K/k or anti-CD40 mAbs for 48 h  (1  ~t 
culture)  and  then  recultured  with  anti- 
CD40 and anti-K/)t mAbs, respectively  (2  "d 
culture).  The anti-APO-I and lgG3 control 
mAbs were added at the onset of the sec- 
ondary cultures.  All cultures were made in 
the  presence  of  mitomycin  C-treated 
HR4C6  cells. [3H]Thymidine  incorpora- 
tion levels were assessed 3 d after initiation 
of the secondary cultures,  after a 16-h pulse. 
Note that the addition of an unrelated IgG1 
mAb  (ctrl lgG1)  instead  of  the  anti-K/~. 
m_Abs to CD40-stimulated cultures neither 
affected the levels of response to anti-CD40 
nor the inhibitory effect of the anti-APO-1 
mAb. 
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Figure  7.  Engagement of the Ag receptor does not 
protect  CD40-activated  GC B  cells from  APO-1- 
mediated apoptosis. Isolated naive, GC, and memory 
B cells were stimulated with the anti-CD40 mAb or 
with the combination of anti-Ig and anti-CD40 Abs, 
in  the  presence  of mitomycin C-treated  HtL4C6 
ceils. Cultures were further supplemented with either 
the anti APO-1  mAb or the IgG3-K control  mAb 
(used at 200 ng/ml). DNA synthesis was assessed at 
day 2, after a 16-h pulse with [3H]thymidine. tLesults 
are expressed as percent response in control cultures 
receiving the IgG3-K control mAb, calculated as de- 
scribed in Materials and Methods. The results corre- 
spond to the mean +-  SD  of the values calculated 
from three different experiments. 
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Figure 8.  Hypothetical model for the immunoregulatory role of APO-1 
on B cell responses. The assumption that the APO-1-L and CD40-L can 
both be expressed on Ag-activated CD4 + T cells predicts that B cells can 
be signaled both via APO-1  and CD40 upon interaction  with T  cells. 
Occupancy of the  Ag receptor  on B  cells prevents the delivery of the 
death signal via APO-1 and thus ensures that the Ag-specific B cell clones 
correlated with  a defective slg signaling consecutive to the 
loss of slgM expression (33).  Therefore,  in a  normal situa- 
tion, the blocked slg signaling in tolerant t3 cells would en- 
sure that  they remain vulnerable to  the APO-l-mediated 
death  signal,  even  after  binding  of  the  self-Ag.  Conse- 
quently,  specific  or  bystander  interaction  with  primed  T 
cells would result in their demise, On the contrary, the re- 
duced expression of APO- 1 in lpr/lpr mice precludes elimi- 
nation of self-reactive B  cells and allows for their stimula- 
tion consecutive to misdirected T  cell help. 
The  observation  that  engagement  of  the  Ag  receptor 
failed  to  protect  anti-CD40--activated  GC  B  cells  from 
APO-l-mediated  apoptosis is intriguing and deserves fur- 
ther  comment.  The  recent description  that  CD44  can be 
expressed at low levels on centrocytes (34) raised the possi- 
bihty that our GC B  cell isolation procedure,  based on the 
depletion of CD44-bearing cells, could introduce a bias fa- 
voring the recovery of centroblasts to the detriment of cen- 
trocytes.  Centroblasts are  currently described as expressing 
low levels ofslgs  (1)  and are not expected to connect with 
T  cells, which are mostly located in the light zone of GC 
(35). Thus, the use of centroblasts to study events that take 
place in the light zone of GC would have no physiological 
relevance,  However,  this  hypothesis  can be  ruled  out  by 
two distinct observations. First, our GC B  cell populations 
contained on average 46 _  5% of centrocytes, identified on 
are protected from APO-l-mediated apoptosis. The bystander activation 
of B cells whose specificity is unrelated to the ongoing response may be 
promoted by engagement of CD40.  In this situation, because of the lack 
of slg cross-linking, the dual triggering of CD40 and APO-I will cause 
the demise of the unwanted B cell clones. 
1386  APO-l-dependent Apoptosis of Human B Cell Subsets the basis of their lack of CD77 expression (19, 34). Second, 
engagement  of the  Ag receptor  failed  to  protect  CD40- 
activated  centrocytes,  (recovered  after  immunomagnetic 
depletion of CD77 + cells) from APO-l-induced apoptosis 
(data not shown). It is possible that additional costimulatory 
signals,  provided  by  the  GC  microenvironment  are  re- 
quired together with those delivered through slgs to pro- 
tect  GC B  cells  from the  APO-l-mediated  death  signal. 
This notion  is supported by recent data showing that en- 
gagement of the Ag receptor on GC B  cells by soluble Ag 
induces  their apoptosis  (36,  37),  thus,  suggesting that  the 
Ag has to be taken up from follicular dendritic cells  to al- 
low  delivery of a  rescue  signal  through  slgs.  A  plausible 
scenario  could  be  that  some  of the  membrane  receptors 
that are triggered when centrocytes bind to follicular den- 
dritic  cells  are  necessary  to  complement the  signal  trans- 
duced  by  the  Ag  receptor  in  order  to  afford protection 
against  APO-l-mediated  apoptosis.  If this  assumption  is 
correct,  GC B  cells  that fail to  estabhsh close interactions 
with follicular dendritic cells (such as the low affinity B cell 
mutants)  would remain fully susceptible to APO-l-medi- 
ated cell death, even if the Ag receptor has been engaged. 
The  finding  that  B  cells  are  no  longer  protected  from 
APO-l-dependent  apoptosis  when  the  Ag  receptor  and 
CD40 are triggered separately, supports a model in which 
these  two  signaling pathways  need  to  be  contemporane- 
ously activated to block the generation of the death signal 
transduced via APO-1. In vivo, cohgation of the Ag recep- 
tor and CD40 is likely to occur at least during the primary 
response, when naive B, T, and interdigitating cells  (IDC) 
are brought into close proximity. In this particular cellular 
context, B  cells  can concomitantly be signaled by the na- 
tive  Ag presented  by the  IDC  and  by the  CD40-L  ex- 
pressed on the adjacent activated T  cell. We can only spec- 
ulate  on the  molecular mechanism whereby triggering of 
slgs  protects  anti-CD40-activated  naive  and  memory B 
cells from APO-l-mediated apoptosis. Although we found 
that the  cohgation of slgs and  CD40 induced  a moderate 
decrease  in  the  density  of APO-1  expression  on  B  cells 
(data  not  shown),  it  remains  diffcult  to  conclude  that 
downregulation  of the APO-1  receptor is the  sole deter- 
mining factor accounting for the  acquisition  of resistance 
against APO-l-induced  apoptosis. We favor the idea that 
the Ag receptor dehvers short-hved intracellular signals that 
interfere with the CD40-mediated activation of the intra- 
cellular death pathway used by the APO-1  receptor.  The 
signaling cascade that transmits the APO-l-mediated death 
signal has recently been shown to involve activation of ty- 
rosine kinases (38) and Ras through the release of ceramide 
(39)  and to converge on increasing the activity of an ICE- 
like protease (40,  41). It has also been reported that the ex- 
pression of protein  tyrosine phosphatases interacting with 
the cytosolic domain of APO-1  is required for transducing 
the APO-l-mediated apoptosis signal (42,  43). These find- 
ings  should  provide  interesting  clues  for  future  studies 
aimed at unravelling the molecular mechanism responsible 
for the blockade of the APO-1  signahng pathway brought 
about by cross-hnking of the Ag receptor. 
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